JSA advised Signet Healthcare Partners in its investment in Laxai Lifesciences Private Limited (“Laxai India“), a company engaged in the business of contract research, drug discovery and contract manufacturing of active pharmaceutical ingredients for innovator pharmaceutical, biotech, and specialty chemicals companies globally.
The complex deal involved a restructuring and consolidation of the existing promoter entities of Laxai India into Laxai Inc., a newly incorporated U.S. holding company, into which Signet subsequently invested. The investment proceeds were used to acquire an U.S. FDA and EU approved pharmaceutical manufacturing facility and associated business from Therapiva Private Limited and to acquire equity interests held by non-promoter shareholders.
The JSA lead transaction team comprised Partner – Rohitashwa Prasad and Associate – Adil Khan. Partner – Rajeev Reddy and Principal Associate – Purnachandra Rao advised on local law issues, particularly, real estate matters. Company Secretary – Alisha Chawla and Assistant Company Secretary – Sourabh Jain provided company secretarial support. Partner & Head of Practice (Direct Tax) – Kumarmangalam Vijay, Senior Associate – Divyam Mittal, and Associate – Shiv Singhal advised on Direct Tax matters. Partner & Head of Practice (Indirect Tax) – Manish Mishra, Senior Associate – Shikha Parmar, and Associate – Meghna Mittal advised on Indirect Tax matters. Partner – Dhirendra Negi advised on the dispute resolution structure in the transaction documents. Partner – Lakshmi Ramachandran advised on employment law-related issues.
Alisha has extensive experience in handling day-to-day secretarial compliance of the companies incorporated in India particularly having foreign investments, downstream investments, etc. She has hands on experience in Company Law compliances along with the FEMA compliances.